APA (7th ed.) Citation

EA, K., PJ, H., RT, K., YP, M., JM, M., SW, E., . . . R, G. (2020). Preclinical evaluation of the combination of AZD1775 and irinotecan against selected pediatric solid tumors: A Pediatric Preclinical Testing Consortium report. Pediatric blood & cancer, 67(5), e28098. https://doi.org/10.1002/pbc.28098

Chicago Style (17th ed.) Citation

EA, Kolb, et al. "Preclinical Evaluation of the Combination of AZD1775 and Irinotecan Against Selected Pediatric Solid Tumors: A Pediatric Preclinical Testing Consortium Report." Pediatric Blood & Cancer 67, no. 5 (2020): e28098. https://doi.org/10.1002/pbc.28098.

MLA (9th ed.) Citation

EA, Kolb, et al. "Preclinical Evaluation of the Combination of AZD1775 and Irinotecan Against Selected Pediatric Solid Tumors: A Pediatric Preclinical Testing Consortium Report." Pediatric Blood & Cancer, vol. 67, no. 5, 2020, p. e28098, https://doi.org/10.1002/pbc.28098.